ATARA Biotherapeutics (ATRA) Announces Proposed Common Share & Pre-Funded Warrants Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St indexes climb after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
ATARA Biotherapeutics (ATRA) Prices 12.63M Share Common Offering at $11.32/Sh
May 27, 2020 5:57 AM EDTAtara Biotherapeutics, Inc. (NASDAQ: ATRA) today announced the pricing of an underwritten public offering of 12,633,039 shares of its common stock at a price to the public of $11.32 per share and, to certain investors, pre-funded warrants to purchase 2,866,961 shares of its common stock at a purchase... More
ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN
May 26, 2020 7:05 AM EDTAtara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop treatments for patients with severe diseases, including solid tumors, hematologic cancers and autoimmune disease, today announced the presentation of additional safety and efficacy data from its ongoing Phase 1 study of ATA188 for the treatment of progressive... More
ATARA Biotherapeutics (ATRA) call put ratio 7.3 calls to 1 put with focus on June 20 calls
May 22, 2020 2:24 PM EDTATARA Biotherapeutics (NASDAQ: ATRA) call put ratio 7.3 calls to 1 put with focus on June 20 calls
UPDATE: ATARA Biotherapeutics (ATRA) Trades at High, Up 20%
May 22, 2020 2:13 PM EDT(Updated - May 22, 2020 2:18 PM EDT)
ATARA Biotherapeutics (NASDAQ: ATRA) climbed 20% Friday afternoon. The company was set to present ATA188 data in MS at the EAN Congress today.
... More